Protease inhibitors block apoptosis at intermediate stages: a compared analysis of DNA fragmentation and apoptotic nuclear morphology.
The possible correlation between DNA digestion and changes in nuclear morphology in apoptosis was studied by blocking the apoptotic process at intermediate stages. The apoptogenic action of three drugs: etoposide, puromycin, tributyltin, was contrasted with protease inhibitors with different specificity on U937 cells. The inhibitors interfered with the development of the apoptotic features without shifting cell death to necrosis: treated cells showed abnormal morphologies, which could be recognized as intermediate stages of apoptosis; accordingly, DNA analysis showed an inhibitor-dependent block of the apoptotic DNA digestion. The comparison between size of DNA fragments and nuclear morphology suggested the following correlations: loss of normal nuclear shape with the appearance of a > or = 2 Mb DNA band; ongoing chromatin condensation with the progressive DNA digestion up to 50 kb; nuclear fragmentation with DNA laddering. Protease inhibitors in etoposide-treated cells did not allow the formation of 700-300 kb fragments, suggesting that they possibly derive from a cell-mediated effect.
Dipartimento di Biologia, Università di Roma Tor Vergata, Italy.
L
L
Ghibelli
V
V
Maresca
S
S
Coppola
G
G
Gualandi
D017209:Apoptosis / Q000187:drug effects*; D002460:Cell Line; D002467:Cell Nucleus / Q000648:ultrastructure*; D002843:Chromatin / Q000648:ultrastructure; D004247:DNA / Q000378:metabolism*; D005047:Etoposide / Q000494:pharmacology; D007700:Kinetics; D011480:Protease Inhibitors / Q000494:pharmacology*; D011691:Puromycin / Q000494:pharmacology; D014220:Trialkyltin Compounds / Q000494:pharmacology
D002843:Chromatin; D011480:Protease Inhibitors; D014220:Trialkyltin Compounds; D011691:Puromycin; C011559:tributyltin; D005047:Etoposide; D004247:DNA